Literature DB >> 16619984

Aggressive fibromatosis--impact of prognostic variables on management.

V Sharma1, D N Chetty, B Donde, M Mohiuddin, A Giraud, S Nayler.   

Abstract

OBJECTIVE: To determine the impact of prognostic variables on local control in patients with aggressive fibromatosis treated with or without radiation.
MATERIALS AND METHODS: Forty-two patients presenting to the combined sarcoma clinic at Johannesburg Hospital with aggressive fibromatosis from 1990 to 2003 were analysed retrospectively. There were 14 males and 28 females. The lesions involved the head and neck in 6 cases (14%), the thorax in 6 (14%), the extremities in 19 (45%) and the abdomen in 11 (26%). Thirty-seven patients (88%) presented to the clinic for the first time, whereas 5 (12%) had recurrent disease at presentation. Fifteen patients (36%) underwent excision only, 15 (36%) had excision followed by postoperative radiation, 8 (19%) had biopsy only, and 4 (9%) had radiation only. The median dose of radiation was 60 Gy (range 9 - 70 Gy).
RESULTS: One patient had local failure following excision and postoperative radiation therapy. The local control was 100% for surgery alone and 86% for surgery followed by postoperative radiation at > or = 24 months. On univariate analysis, age, sex, positive margins, primary or recurrent presentation, site of involvement and initial treatment did not affect local control significantly. Eight of 19 patients (42%) receiving radiation developed severe moist desquamation following treatment, and all these patients had doses of 60 Gy or more.
CONCLUSION: Surgery with or without radiation therapy gave excellent local control. The addition of radiation therapy to surgery as well as other known prognostic parameters did not impact on local control. The morbidity of radiation treatment is considerable, as noted in this series, and adjuvant radiation therapy should therefore be considered only in situations where the risk of recurrence and the morbidity of re-excision are high.

Entities:  

Mesh:

Year:  2006        PMID: 16619984

Source DB:  PubMed          Journal:  S Afr J Surg        ISSN: 0038-2361            Impact factor:   0.375


  5 in total

1.  Mesenteric histiocytosis or only an inflammatory infiltration of histiocytes? A case report from a surgical point of view.

Authors:  Florian Höhler; Karl-Heinz Dietl; Karel Novak; Joachim Giedl; Christian Paetzel
Journal:  Int Surg       Date:  2012 Jul-Sep

2.  MRI may be used as a prognostic indicator in patients with extra-abdominal desmoid tumours.

Authors:  Firouzeh Kamali; Wei-Lien Wang; B A Guadagnolo; Patricia S Fox; Valerae O Lewis; Alexander J Lazar; Anthony P Conley; Vinod Ravi; Mohammad Toliyat; Harshad S Ladha; Brian P Hobbs; Behrang Amini
Journal:  Br J Radiol       Date:  2015-11-18       Impact factor: 3.039

Review 3.  A systematic review of active treatment options in patients with desmoid tumours.

Authors:  X Yao; T Corbett; A A Gupta; R A Kandel; S Verma; J Werier; M Ghert
Journal:  Curr Oncol       Date:  2014-08       Impact factor: 3.677

4.  Treatment and follow-up strategies in desmoid tumours: a practice guideline.

Authors:  M Ghert; X Yao; T Corbett; A A Gupta; R A Kandel; S Verma; J Werier
Journal:  Curr Oncol       Date:  2014-08       Impact factor: 3.677

5.  Four different treatment strategies in aggressive fibromatosis: A systematic review.

Authors:  Jojanneke M Seinen; Maarten G Niebling; Esther Bastiaannet; Betty Pras; Harald J Hoekstra
Journal:  Clin Transl Radiat Oncol       Date:  2018-03-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.